Dotinurad

DB16145InvestigationalSmall molecule

Dotinurad is under investigation in clinical trial NCT03372200 (Febuxostat-controlled, Double-blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout).

Mechanism: Pharmacologically active on Solute carrier family 22 member 12
Curator reviewed
Formula / weight: C₁₄H₉Cl₂NO₄S · 358.19 g/mol (avg)
Code names: FYU-981

Resolves to

Compound

UNII305EB53128CAS1285572-51-1

Structure

InChIKeyVOFLAIHEELWYGO-UHFFFAOYSA-NSMILESOC1=C(Cl)C=C(C=C1Cl)C(=O)N1CS(=O)(=O)C2=CC=CC=C12

Targets

Q96S37SLC22A12

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Drug interactionStructured to mechanism, not free text

17Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dotinurad, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account